Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Sinus Thrombosis, Intracranial | 3 | 2021 | 550 | 0.83 | Why? |
| Cerebral Ventricles | 1 | 2017 | 16 | 0.73 | Why? |
| Ventricular Outflow Obstruction | 1 | 2017 | 23 | 0.72 | Why? |
| Ubiquitin Thiolesterase | 1 | 2017 | 69 | 0.68 | Why? |
| Hydrocephalus | 1 | 2017 | 139 | 0.66 | Why? |
| Cerebral Hemorrhage | 3 | 2018 | 820 | 0.60 | Why? |
| Intracranial Hemorrhages | 2 | 2021 | 1170 | 0.57 | Why? |
| Brain Injuries, Traumatic | 1 | 2017 | 381 | 0.48 | Why? |
| Stroke | 6 | 2021 | 8839 | 0.45 | Why? |
| Prone Position | 1 | 2019 | 1861 | 0.33 | Why? |
| Venous Thrombosis | 1 | 2021 | 2739 | 0.30 | Why? |
| Health Status | 1 | 2019 | 3259 | 0.29 | Why? |
| Visual Analog Scale | 1 | 2019 | 151 | 0.19 | Why? |
| Ventriculoperitoneal Shunt | 1 | 2017 | 29 | 0.18 | Why? |
| Brain Ischemia | 3 | 2018 | 2813 | 0.18 | Why? |
| Glasgow Coma Scale | 1 | 2017 | 249 | 0.16 | Why? |
| Magnetic Resonance Imaging | 6 | 2021 | 6551 | 0.16 | Why? |
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 317 | 0.15 | Why? |
| Geography | 1 | 2021 | 1801 | 0.14 | Why? |
| Thrombolytic Therapy | 3 | 2021 | 2218 | 0.14 | Why? |
| White Matter | 1 | 2017 | 369 | 0.13 | Why? |
| Health Expenditures | 1 | 2021 | 904 | 0.13 | Why? |
| Thrombectomy | 2 | 2021 | 2272 | 0.12 | Why? |
| African Americans | 2 | 2018 | 3363 | 0.12 | Why? |
| Health Status Disparities | 2 | 2020 | 4072 | 0.11 | Why? |
| Hospital Mortality | 4 | 2021 | 22087 | 0.09 | Why? |
| Risk | 1 | 2021 | 5288 | 0.09 | Why? |
| Image Processing, Computer-Assisted | 1 | 2017 | 1383 | 0.09 | Why? |
| Hospitals, Pediatric | 1 | 2019 | 1792 | 0.09 | Why? |
| Tertiary Care Centers | 3 | 2020 | 8248 | 0.09 | Why? |
| International Cooperation | 1 | 2021 | 3436 | 0.08 | Why? |
| Pilot Projects | 1 | 2019 | 5182 | 0.08 | Why? |
| Fibrinolytic Agents | 1 | 2018 | 1702 | 0.08 | Why? |
| Brain | 2 | 2021 | 5133 | 0.08 | Why? |
| Male | 12 | 2021 | 367725 | 0.08 | Why? |
| Female | 12 | 2021 | 380317 | 0.07 | Why? |
| Risk Factors | 6 | 2020 | 71621 | 0.07 | Why? |
| Parkinson Disease | 1 | 2017 | 1414 | 0.07 | Why? |
| Pediatrics | 1 | 2019 | 2969 | 0.06 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.06 | Why? |
| Aged | 7 | 2021 | 215776 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.06 | Why? |
| Humans | 16 | 2021 | 930598 | 0.06 | Why? |
| Adult | 6 | 2021 | 244371 | 0.05 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.05 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.05 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.05 | Why? |
| Odds Ratio | 2 | 2021 | 5861 | 0.04 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.04 | Why? |
| Tennessee | 1 | 2018 | 243 | 0.04 | Why? |
| Biomarkers | 2 | 2017 | 23361 | 0.04 | Why? |
| Contraindications, Drug | 1 | 2018 | 281 | 0.04 | Why? |
| Neural Pathways | 1 | 2017 | 155 | 0.04 | Why? |
| United States | 3 | 2020 | 46150 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.04 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.04 | Why? |
| Chi-Square Distribution | 1 | 2018 | 961 | 0.04 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.04 | Why? |
| Infant | 1 | 2017 | 30274 | 0.03 | Why? |
| Disability Evaluation | 1 | 2018 | 671 | 0.03 | Why? |
| Natural Language Processing | 1 | 2018 | 436 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2018 | 1224 | 0.03 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.03 | Why? |
| Neuroimaging | 1 | 2021 | 1106 | 0.03 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.03 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.03 | Why? |
| Retrospective Studies | 3 | 2020 | 105322 | 0.03 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.03 | Why? |
| Endovascular Procedures | 1 | 2021 | 1302 | 0.03 | Why? |
| Greece | 1 | 2018 | 2091 | 0.03 | Why? |
| Thrombophilia | 1 | 2020 | 1935 | 0.02 | Why? |
| Research | 1 | 2021 | 2115 | 0.02 | Why? |
| Leukocyte Count | 1 | 2017 | 3178 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.02 | Why? |
| Patient Safety | 1 | 2018 | 4885 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2018 | 88759 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.01 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.01 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |